QEA
- Product code
- QEA
- Device name
- Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
- Device class
- Class 2
- 21 CFR
- 21 CFR 882.1455
- Medical specialty
- Neurology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 7 (all years; only the last 3 years are listed here)
FDA classification definition
A traumatic brain injury eye movement assessment aid is a prescription device that uses a patients tracked eye movements to provide an interpretation of the functional condition of the patients brain. This device is an assessment aid that is not intended for standalone detection or diagnostic purposes.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K254086 | 2026-06-05 | Oculogica, Inc. | EyeBOX SNAP | |
| K242116 | 2025-04-04 | Oculogica, Inc. | EyeBOX EBX-4.1 |
Official FDA classification page: QEA
Classification and pathway per current FDA publications. Data from openFDA (CC0).